Michael Forbes, CEO of Adastra, reported in his Original press release: “Harm reduction is really a critically essential and mainstream topic, and we have been keeping with the forefront of drug rules throughout the board.”Verifying the things they say is difficult, but the things they explain stacks up with the public history and what men and